Relapsing fever future or investigational therapies: Difference between revisions

	Relapsing fever Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Relapsing fever from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Relapsing fever future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Relapsing fever future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Relapsing fever future or investigational therapies
CDC on Relapsing fever future or investigational therapies
Relapsing fever future or investigational therapies in the news
Blogs on Relapsing fever future or investigational therapies
Directions to Hospitals Treating Relapsing fever
Risk calculators and risk factors for Relapsing fever future or investigational therapies

Latest revision as of 02:28, 25 September 2020

@@ Line 2: / Line 2: @@
 {{Relapsing fever}}
 ==Overview==
-*Currently, no [[vaccine]] against relapsing fever is available, but research continues.
+*Research continues to find a [[vaccine]] against [[relapsing fever]].
 ==Future or investigational therapies==
+*Research continues to find a [[vaccine]] against [[relapsing fever]].
-Currently, no vaccine against relapsing fever is available, but research continues. Developing a vaccine is very difficult because the spirochetes avoid the immune response of the infected person (or animal) through antigenic variation (changing its surface proteins).
 ==References==